Bizarre Patents
Method and apparatus for making a drink hop along a bar or counter
A method for generating a drink which appears to hop from a remote spot on the bar or counter and take one or more leaps, before landing in a patron's glass.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Application No. | Application Title | Issue Date |
| 20070196332 | Cytotoxic agents comprising taxanes and their therapeutic use A cytotoxic agent comprising one or more taxanes linked to a cell binding agent. A therapeutic composition for killing selected cell populations comprising: (A) a cytotoxic amount of one or more taxanes covalently bonded to a cell binding agent through a linking group, ... | 08/23/2007 |
| 20070172448 | Method for detecting the specificity of activated lymphocyte A method for detecting the specificity of activated lymphocytes is provided. The present method can be used to detect the specificity of activated lymphocytes in recipients or patients after organ transplantation or being infected by pathogenic microorganism or vaccinat... | 07/26/2007 |
| 20070172459 | Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules Compositions of modified cytokines and uses thereof generated using processes and systems for the high throughput directed evolution of peptides and proteins, particularly cytokines that act in complex biological settings, are provided. Also provided are modified cytoki... | 07/26/2007 |
| 20070148131 | Methods and compositions for needleless delivery of binding partners The present invention relates, in part, to methods and compositions for needleless delivery of macromolecules to a subject. In one aspect, the methods and compositions involve administering to the subject a delivery construct comprising a carrier construct non-covalentl... | 06/28/2007 |
| 20070122384 | Method for treating inflammatory bowel disease A method for treating inflammatory bowel disease by administering interferon beta in conjunction with factor XIII to a mammal afflicted with the disease. The IBD may either be ulcerative colitis or Crohn's disease. The factor XIII used may be recombinant or nonrecombina... | 05/31/2007 |
| 20070087047 | Enhanced circulation effector composition and method A liposome composition comprising small, surface-bound effector molecules is disclosed. The liposomes have a surface layer of hydrophilic polymer chains, for enhanced circulation time in the bloodstream. The effector molecules are attached to the distal ends of the poly... | 04/19/2007 |
| 20070077289 | Cream containing interferon encapsulated with liposome This invention relates to a cream containing interferon encapsulated with liposome, which comprises IFN liposome and cream substrate. The advantage of the cream of the present invention is high efficiency of encapsulation, stable production technique, good homogeneity o... | 04/05/2007 |
| 20070077283 | METHOD OF ENHANCING TRANSMUCOSAL DELIVERY OF THERAPEUTIC COMPOUNDS A composition comprising a biologically active agent and a permeation enhancing lipid wherein the permeation enhancing lipid is a platelet activating factor antagonist or a biologically inactive a platelet activating factor, and increases permeability of the biologicall... | 04/05/2007 |
| 20070059285 | Human serum albumin-free stabilized interferon liquid formulations A stabilized HSA-free liquid pharmaceutical composition is described, which comprises an interferon (IFN), wherein said formulation is a solution that comprises a buffer, a surfactant, an isotonicity agent and an antioxidant. Preferably the interferon is human recombina... | 03/15/2007 |
| 20070025965 | Therapies for renal failure using interferon-beta The present invention provides methods for the treatment, and pharmaceuticals for the use in the treatment, of mammalian subjects having, or at risk of developing, glomerulonephritis or chronic renal failure. The methods involve the administration of IFN-β therapeutics... | 02/01/2007 |
| 20070020227 | Use of truncated cysteine IL28 and IL29 mutants to treat cancers and autoimmune disorders Methods for treating patients with cancer and autoimmune disorders using IL-28 and IL-29 molecules. The IL-28 and IL-29 molecules include polypeptides that have homology to the human IL-28 or IL-29 polypeptide sequence and proteins fused to a polypeptide with IL-28 and ... | 01/25/2007 |
| 20060275252 | Conjugates formed from polymer derivatives having particular atom arrangements Polymeric reagents are provided comprising a moiety of atoms arranged in a specific order, wherein the moiety is positioned between a water-soluble polymer and a reactive group. The polymeric reagents are useful for, among other things, forming polymer-active agent conj... | 12/07/2006 |
| 20060269516 | Interferon-IgG fusion The present invention provides, inter alia, polypeptides for the treatment of various diseases such as HCV as well as methods of treatment and methods of making the polypeptides. ... | 11/30/2006 |
| 20060246033 | Injectable bulking agent compositions Compositions comprising comminuted extracellular matrix material, a growth factor and a telocollagen are provided. The compositions are useful, for example, as injectable bulking agents. Preferably, the compositions comprise collagen having a telopeptide region. ... | 11/02/2006 |
| 20060239965 | Extracellular matrix binding chimeric proteins and methods of use thereof The present invention provides chimeric polypeptides comprising a first polypeptide that binds to a component of extracellular matrix and a second polypeptide that provides for a therapeutic effect. The present invention further provides compositions, including pharmace... | 10/26/2006 |
| 20060233854 | Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same The present invention relates to biodegradable scaffolds composed of a naturally-occurring protein backbone cross-linked by a synthetic polymer. Specifically, the present invention provides PEGylated-fibrinogen scaffold and methods of generating and using same for treat... | 10/19/2006 |
| 20060228326 | Active specific immunotherapy of cancer metastasis The present invention provides for the treatment of a subject with occult brain metastasis. The treatment relies on administering to the subject a composition comprising an immunomodulatory polypeptide and a baculovirus-insect cell preparation. This composition has a un... | 10/12/2006 |
| 20060228700 | Novel retrovirus associated with myelodysplastic syndromes and uses thereof The present invention relates first, to the identification of a novel retrovirus and the novel nucleotide sequences encoding a retroviral polymerase gene (POL nucleotides) associated with the existence of MDS and MDS associated disorders. The present invention further r... | 10/12/2006 |
| 20060216242 | Suspending vehicles and pharmaceutical suspensions for drug dosage forms Suspending vehicles and pharmaceutical suspensions that include a biocompatible polymer that can be combined with a hydrophobic solvent and a hydrophilic solvent to provide vehicles and suspensions that are substantially free of stiff gels upon contact with an aqueous m... | 09/28/2006 |
| 20060204473 | Synthetic hyperglycosylated, and hyperglycosylated protease-resistant polypeptide variants, oral formulations and methods of using the same The present invention provides synthetic Type I interferon receptor polypeptide agonists comprising consensus or hybrid Type I interferon receptor polypeptide agonists, containing one or more native or non-native glycosylation sites. The present invention provides synth... | 09/14/2006 |
| 20060198821 | Elevation of adenosine level by cytokine-induced expression of cd73 This invention concerns a method of inducing an elevated level of adenosine in an individual by administering to said individual an effective amount of either i) recombinant protein CD73 or ii) a cytokine or another factor-being capable of inducing endothelial CD73 expr... | 09/07/2006 |
| 20060159626 | Method for administering a cytokine to the central nervous system and the lymphatic system The present invention is directed to a method for delivering cytokines to the central nervous system and the lymphatic system by way of a tissue innervated by the trigeminal nerve and/or olfactory nerve. Cytokines include tumor necrosis factors, interleukins, interferon... | 07/20/2006 |
| 20060159655 | Treating immunological disorders using agonists of interleukin-21 / interleukin-21 receptor Methods and compositions for modulating interleukin-21 (IL-21)/IL-21 receptor (MU-1) activity using agonists of IL-21 or IL-21 receptor (“IL-21R” or “MU-1”), are disclosed. IL-21/IL-21R agonists can be used by themselves or in combination with anti-inflammatory ... | 07/20/2006 |
| 20060104946 | Method for treating inflammatory bowel disease A method for treating inflammatory bowel disease by administering interferon beta in conjunction with factor XIII to a mammal afflicted with the disease. The IBD may either be ulcerative colitis or Crohn's disease. The factor XIII used may be recombinant or nonrecombina... | 05/18/2006 |
| 20060062758 | Tight junction modulator peptide PN159 for enhanced mucosal delivery of therapeutic compounds Compositions and methods are provided that include a biologically active agent and a permeabilizing agent effective to enhance mucosal delivery of the biologically active agent in a mammalian subject, in which the permeabilizing peptide is PN159, PN159 analogues, conjug... | 03/23/2006 |
| 20050220763 | Method of treating idiopathic pulmonary fibrosis with aerosolized IFN-gamma A method of treating idiophathic pulmonary fibrosis (IPF), comprising administering aerosolized interferon-γ in a therapeutically effective amount to achieve improved or ameliorated symptoms of IPF. ... | 10/06/2005 |
| 20050214253 | Interferon-beta fusion proteins and uses A fusion polypeptide is described having the amino acid sequence X-Y-Z, or portion thereof, comprising the amino acid sequence of a glycosylated interferon-beta (X); Y is an optional linker moiety; and Z is a polypeptide comprising at least a portion of a polypeptide ot... | 09/29/2005 |
| 20050208019 | Uses of interferons with altered spatial structure This invention provides a method for preventing or treating Severe Acute Respiratory Syndrome in a subject comprising administering to the subject an effective amount of recombinant super-compound interferon or a functional equivalent thereof. This invention provides a ... | 09/22/2005 |
| 20050181033 | Method for delivering interferons to the intradermal compartment The present invention relates to methods and devices for intradermal delivery of substances, preferably therapeutic substances by targeting the substance to the intradermal compartment of a subject's skin. Substances delivered in accordance with the methods of the inven... | 08/18/2005 |
| 20050180950 | Chemically modified TNF-alpha The invention concerns a derivative of viral regulatory protein or a fragment of viral regulatory protein or of the alpha interferon or a fragment of alpha interferon, which is carboxymethylated, a method for preparing, use of the resulting product in a method of treatm... | 08/18/2005 |
| 20050142120 | Cells expressing anti-Fc receptor binding components Cells transformed to express on their surface a component which binds to an Fc receptor of an effector cell are disclosed. Also disclosed are expression vectors used to transform the cells. Once transformed, the cells bind to effector cells via the Fc receptor of the ef... | 06/30/2005 |
| 20050074882 | Methods and products related to metabolic interactions in disease The invention involves methods of regulating cell growth and division to control disease processes by manipulating mitochondrial metabolism and the expression of cell surface immune proteins. The invention also involves related compositions and screening assays. ... | 04/07/2005 |
| 20050013801 | Methods of treating liver fibrosis and hepatitis c virus infection The present invention provides methods of reducing liver fibrosis; methods of increasing liver function in an individual suffering from liver fibrosis; methods of reducing the incidence of complications associated with HCV and cirrhosis of the liver; methods of reducing... | 01/20/2005 |
| 20050002900 | Method of treating estrogen responsive breast cancer The present invention is directed to a method of treating estrogen responsive breast cancer in an individual comprising administering to an individual a therapeutically effective estradiol inhibiting amount of interferon gamma (IFN-γ) and/for a tumor necrosis factor (T... | 01/06/2005 |
